In 2017, the federal government introduced new regulations for the drug review board.
access to medicines
Drugs were approved in the U.S. 469 days earlier (on average) than in Canada.
More regulation will likely lead to slower and more limited access to drugs.
Canadians can also expect tax hikes to pay for the government drug program.
In a bid to get even steeper drug discounts, Health Canada recently proposed changes to our reference-pricing system.
Ottawa’s changes may delay the launch of new innovative medications in Canada.
Under Medicare in the U.S., private insurers compete to offer coverage within regions.